Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Concomitant Treatment of Permanent Atrial Fibrillation

Study:

A Prospective, Multi-center Study With Case Matched Controls to Evaluate the Safety and Efficacy of the AtriCure Bipolar System for the Treatment of Continuous Atrial Fibrillation as Adjunct Therapy to Elective Open Heart Surgery

Rationale:

n/a

Purpose:

RESTORE-SR study is a multi-center, prospective, nonrandomized study with case matched concurrent controls to evaluate the safety and efficacy of the AtriCure Bipolar System

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Atrial Fibrillation Device: Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System Phase 3

Verified by AtriCure, Inc. January, 2012

Sponsored by: AtriCure, Inc.
Information provided by: AtriCure, Inc.
ClinicalTrials.gov identifier: NCT00566787

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic
Cleveland, Ohio 44195
United States

A. Marc Gillinov, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site